![Targeting Inflammation in Atherosclerosis: Therapeutic Targets and Mode of Action](https://assets.radcliffecardiology.com/s3fs-public/podcast/2024-03/DELV-6311_NN_Kaski_Libby.png?VersionId=anAI4VD3DnJlw3RHVAtllAyBHIWbnMvH)
Targeting Inflammation in Atherosclerosis: Therapeutic Targets and Mode of Action
Prof Juan Carlos Kaski (St George’s University of London, UK) alongside Dr Peter Libby (Brigham and Women’s Hospital, Boston, US) provide us with a short and concise discussion regarding Therapeutic Targets and Mode of Action.
Read MoreRead Less
Supported by an unrestricted educational grant from NOVO NORDISK A/S.
Read MoreRead Less
![Targeting Inflammation in Atherosclerosis: Inflammation and Atherosclerosis](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-02/DELV-6313_NN_Kaski_Badimon_1920x1080_1.png?VersionId=NM38Vmrhd0rZkhpzvUCJ8Aj.5OoHyTxR&itok=z6D7Qx1D)
Inflammation and Atherosclerosis – What is the Link with CKD? Join Prof Juan Carlos Kaski (St George’s University of London, UK) and Prof Lina Badimon (Hospital of Santa Creu and San Pau, Barcelona, Spain) as they discuss that very question.
Read More
All Episodes
![View from the Thoraxcenter: EuroPCR 24 Preview](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-07/DELV-21391_IND_EuroPCR24_Thorax_Preview_1920x1080%20%284%29.jpg?VersionId=8qyeeDxvcVDdQZsPgTEhAwVCTc0aODqO&itok=7o8k40g6)
Join interventional experts, Prof Nicolas Van Mieghem and Dr Joost Daemen from Erasmus MC's Thoraxcenter for an insightful preview of the late-breaking science data to look out for at the 2024 EuroPCR meeting.
Read More
![View from the Thoraxcenter: ACC.24 Wrap Up](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-04/DELV-20924_IND_ACC24_Thorax_WrapUp_1920x1080.jpg?VersionId=xzLdpFYniyRYKPTn_ur0Y2fQaS7_opns&itok=sGRB01cj)
Join Prof Nicolas Van Mieghem and Dr Joost Daemen from Erasmus MC, Rotterdam for a deep dive into the late-breaking data presented at ACC.24.
Read More
![ACC.24 Late-breaking Science Preview](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-03/DELV-20712_IND_ACC24_Thorax_Preview_1920x1080.jpg?VersionId=NZKBAeYuVFEq8_A4QuFzbZA.NKmJIsRC&itok=VvuyX-1B)
What’s hot at ACC.24?
Join interventional experts, Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL) to learn more about this year’s key late-breaking and featured science trials that have the potential to shape practice and research.
Read More
Join interventional experts, Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL) to learn more about this year’s key late-breaking and featured science trials that have the potential to shape practice and research.
![VHPSD versus Conventional Catheter Ablation in AF](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2023-12/DELV-17876_RC-Podcast_Pranata_1920x1080.jpg?VersionId=0ilpkImVw.IBhFa4HGsGbSL4yh_oxl_L&itok=IiYOCsWw)
In this episode of the Radcliffe Podcast, we are joined by Dr Raymond Pranata, Dr Mohammad Iqbal and Dr Giky Karwiky (Hasan Sadikin General Hospital, Bandung, Indonesia) as they discuss their recently published systematic review and meta-analysis of very-high-power short-duration ablation as compared to conventional ablation for the treatment of pulmonary vein isolation in atrial fibrillation.
Read More
![View from the Thoraxcenter: AHA 23 Wrap Up](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-01/DELV-18484_AHA23_Thorax_WrapUp_1920x1080.jpg?VersionId=CTt7WafRTqAlQLoC2ccc408sW3gfqwrX&itok=Fi6ZvQl5)
Join Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcentre, Erasmus MC, Rotterdam, NL) as they review the latest late-breaking science data from AHA Scientific Sessions 2023.
They interpret the evidence from five key trials, providing context, asking thought-provoking questions to translate the data into key take-home messages for practice and research.
Read More
They interpret the evidence from five key trials, providing context, asking thought-provoking questions to translate the data into key take-home messages for practice and research.
![View from the Thoraxcenter: TCT 23 Wrap Up](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-01/DELV-18028_TCT_Thorax_WrapUp_1920x1080.jpg?VersionId=WZPyQM5YID8Ja2tTG82JqWVrDY4PW5uI&itok=-bh0NRIv)
Join interventional cardiologists, Prof Nicolas Van Mieghem and Dr Joost Daemen from the Thoraxcenter as they unpack the most impactful late-breaking clinical trials and science data from this year's Transcatheter Cardiovascular Therapeutics Conference.
Dive into this practical and engaging discussion and learn more about the latest data for practice and for research.
Read More
Dive into this practical and engaging discussion and learn more about the latest data for practice and for research.
![ESC 23 Late-breaking Science Wrap Up](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-01/DELV-16042_IND_ESC_ThoraxReview_1920x1080.jpg?VersionId=aKMl08SiVOIisOXa0Kp6ppYSg3T1FuLX&itok=FaPhFNbK)
In this ESC 2023 wrap-up, Prof Van Mieghem and Dr Daemen will dissect the data, evaluating real-world applicability, and distilling findings into actionable insights for clinical practice.
Read More
![View from the Thoraxcenter: ESC 23 Late-breaking Science Preview](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2023-08/DELV-16041_ES23_Thorax_Preview_1920x1080.png?VersionId=vIAYlNblFzty.rxRkj4FYJnXNBwsfViF&itok=7At0VBr2)
In this episode of View of the Thoraxcenter, Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL) preview the hot line and late-breaking data presented at ESC Congress 2023. With their dynamic analysis, they place these highly anticipated trials within a context, highlighting the real-world implications tied to the data releases.
Read More
![Left Main Percutaneous Coronary Revascularization](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2023-07/DELV-15836_RC-Podcast_Alasnag_1920x1080.png?VersionId=3k5Ei8Hy3JGXuU01xNK8kY0YGVYZ2V.M&itok=b3BaXXuM)
In this episode of the Radcliffe Podcast, we are joined by Dr Mirvat Alasnag (King Fahd Armed Forces Hospital, SA), Dr Khalid AlJohani (King Saud University, SA), and Dr Abdulrahman AlMoghairi (Prince Sultan Cardiac Center, SA) as they discuss methods and approaches to left main percutaneous coronary revascularization.
Read More
![Artificial Intelligence in Atrial Fibrillation](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2023-05/DELV-15190_RC-Podcast_Harmon-Lopez_1920x1080%20%283%29.png?VersionId=MoT_llgyx1x4kNfpAxGS.aF18zOhApgi&itok=FJiRsHiz)
In this episode from the Radcliffe Podcast, Dr Francisco Jiminez-Lopez (Mayo Clinic, US) and Dr David Harmon (Mayo Clinic, US) join us to discuss the future of AI in Atrial Fibrillation treatment, based on Dr Harmon's recently published article in AER Journal; 'Artificial intelligence for the detection and treatment of atrial fibrillation'.
Read More
![View from the Thoraxcenter: EuroPCR 24 Preview](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-07/DELV-21391_IND_EuroPCR24_Thorax_Preview_1920x1080%20%284%29.jpg?VersionId=8qyeeDxvcVDdQZsPgTEhAwVCTc0aODqO&itok=7o8k40g6)
Join interventional experts, Prof Nicolas Van Mieghem and Dr Joost Daemen from Erasmus MC's Thoraxcenter for an insightful preview of the late-breaking science data to look out for at the 2024 EuroPCR meeting.
Read More
![View from the Thoraxcenter: ACC.24 Wrap Up](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-04/DELV-20924_IND_ACC24_Thorax_WrapUp_1920x1080.jpg?VersionId=xzLdpFYniyRYKPTn_ur0Y2fQaS7_opns&itok=sGRB01cj)
Join Prof Nicolas Van Mieghem and Dr Joost Daemen from Erasmus MC, Rotterdam for a deep dive into the late-breaking data presented at ACC.24.
Read More
![ACC.24 Late-breaking Science Preview](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-03/DELV-20712_IND_ACC24_Thorax_Preview_1920x1080.jpg?VersionId=NZKBAeYuVFEq8_A4QuFzbZA.NKmJIsRC&itok=VvuyX-1B)
What’s hot at ACC.24?
Join interventional experts, Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL) to learn more about this year’s key late-breaking and featured science trials that have the potential to shape practice and research.
Read More
Join interventional experts, Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL) to learn more about this year’s key late-breaking and featured science trials that have the potential to shape practice and research.
![VHPSD versus Conventional Catheter Ablation in AF](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2023-12/DELV-17876_RC-Podcast_Pranata_1920x1080.jpg?VersionId=0ilpkImVw.IBhFa4HGsGbSL4yh_oxl_L&itok=IiYOCsWw)
In this episode of the Radcliffe Podcast, we are joined by Dr Raymond Pranata, Dr Mohammad Iqbal and Dr Giky Karwiky (Hasan Sadikin General Hospital, Bandung, Indonesia) as they discuss their recently published systematic review and meta-analysis of very-high-power short-duration ablation as compared to conventional ablation for the treatment of pulmonary vein isolation in atrial fibrillation.
Read More
![View from the Thoraxcenter: AHA 23 Wrap Up](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-01/DELV-18484_AHA23_Thorax_WrapUp_1920x1080.jpg?VersionId=CTt7WafRTqAlQLoC2ccc408sW3gfqwrX&itok=Fi6ZvQl5)
Join Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcentre, Erasmus MC, Rotterdam, NL) as they review the latest late-breaking science data from AHA Scientific Sessions 2023.
They interpret the evidence from five key trials, providing context, asking thought-provoking questions to translate the data into key take-home messages for practice and research.
Read More
They interpret the evidence from five key trials, providing context, asking thought-provoking questions to translate the data into key take-home messages for practice and research.